Have a personal or library account? Click to login
Correlation Between Cervical Cytology and Histopathological Cervical Biopsy Findings According to the Bethesda System / Stepen Korelacije Cervikalne Citologije Po Bethesda Klasifikaciji Sa Patohistološkim Nalazima Cervikalne Biopsije
2. -Department for Prevention and Control of Noncommunicable Diseases. Cancer incidence and mortality in central Serbia 2011 Cancer registry of central Serbia. Beograd: Institute of Public Health of Serbia “Dr Milan Jovanović Batut”. 2013. report No. 13.
4. Matovina M, Sabol I, Grubisic G, Gasperov NM, Grce M. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 2009;113(1):120-7. PubMed PMID: 19157528. doi: 10.1016/j.ygyno.2008.12.00410.1016/j.ygyno.2008.12.004
10. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes, 2nd ed. New York: Springer Science; New York: Business Media, LLC.. 2004.
12. Pogacnik A, et al. . Uputstva za tumačenje briseva cervikalne citologije-klasifikacija prema Bethesdi. Beograd: Institut za javno zdravlje Srbije “Dr Milan Jovanović- Batut”. 2012. (prevod slovenačke skraćene verzije).
18. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003;127(8):946-9. PubMed PMID: 1287316610.5858/2003-127-946-FTDFTA12873166
20. Chivukula M, Shidham VB. ASC-H in Pap test - definitive categorization of cytomorphological spectrum. Cytojournal 2006;3(1):14. doi: 10.1186/1742-6413-3-1410.1186/1742-6413-3-14152497916686950
21. Barcelos ACM, Antoniazi Michelin M, Adad SJ, Candido Murta EF. Atypical Squamous Cells of Undetermined Significance: Bethesda Classification and Association with Human Papillomavirus. Infectious Diseases in Obstetrics and Gynecology 2011;904674:9. doi: 10.1155/2011/90467410.1155/2011/904674313250921760701
22. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285(11):1500-5. PubMed PMID: 1125542710.1001/jama.285.11.150011255427
25. Perisi Z, Plesinac-Karapandzic V, Dzinic M, Zamurovic M, Perisic N. Cervical cancer screening in Serbia. Vojnosanitetski pregled 2013;70(1):86-89. doi: 10.2298/ VSP1301086P10.2298/VSP1301086P
27. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007;195(11):1582-9. PubMed PMID: 1747142710.1086/51678417471427
28. Stoler MH, Wright TC, Sharma A, Apple R, Gutekunst K, Wright TL. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 2011;135(3):468-75. PubMed PMID: 21350104. doi: 10.1309/AJCPZ5JY6- FCVNMOT
29. Wright TC, Massad L, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197(4):346-55. PubMed PMID: 1790495710.1016/j.ajog.2007.07.04717904957
30. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf J, Da SD, Prendiville W. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008;19(6):342-54. PubMed PMID: 19040546. doi: 10.1111/j.1365-2303. 2008.00623.